GPT and hyperuricemia: After co-administration of micronized fenofibrate and pitavastatin, 10 subjects (41.7% of 24 subjects) experienced 15 reported ADRs, including 4 cases of elevated CPK, 3 cases of increased alanine transaminase (ALT), 2 cases of increased aspartate transaminase (AST) levels, and one case each of decreased WBC, hyperuricemia, increased LDH, abnormal urinary occult blood, abnormal urinary RBC, and diarrhea.